CD19
B-cell surface antigen targeted by approved CAR-T therapies (axicabtagene ciloleucel, tisagenlecleucel, lisocabtagene maraleucel) and bispecific antibody blinatumomab.
No Drugs found for this biomarker.
B-cell surface antigen targeted by approved CAR-T therapies (axicabtagene ciloleucel, tisagenlecleucel, lisocabtagene maraleucel) and bispecific antibody blinatumomab.
No Drugs found for this biomarker.